Loading...
Please wait, while we are loading the content...
Similar Documents
Efficacy and predictors of response of lenalidomide and rituximab in patients with treatment-naive and relapsed CLL
| Content Provider | Scilit |
|---|---|
| Author | O'brien, Susan M. Strati, Paolo Takahashi, Koichi Peterson, Christine B. Keating, Michael J. Thompson, Philip A. Daver, Naval G. Jain, Nitin Burger, Jan A. Estrov, Zeev Kantarjian, Hagop M. Wierda, William G. Futreal, P. Andrew Ferrajoli, Alessandra |
| Copyright Year | 2019 |
| Description | Key Points The combination of lenalidomide and rituximab is highly effective in patients with CLL and low baseline β2-microglobulin levels. Mutations in the NOTCH signaling pathway are associated with worse outcome in patients with CLL treated with lenalidomide and rituximab. |
| Related Links | https://ashpublications.org/bloodadvances/article-pdf/3/9/1533/784493/advances031336.pdf |
| Ending Page | 1539 |
| Page Count | 7 |
| Starting Page | 1533 |
| DOI | 10.1182/bloodadvances.2019031336 |
| Journal | Blood advances |
| Issue Number | 9 |
| Volume Number | 3 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2019-05-10 |
| Access Restriction | Open |
| Subject Keyword | Hematology Treatment Efficacy Bone Marrow Relapsed Notch Pfs Cll Optimize Naive Shorter Journal: Blood advances (Vol- 106, Issue- 9) |
| Content Type | Text |
| Resource Type | Article |